UA97387U - Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis - Google Patents
Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosisInfo
- Publication number
- UA97387U UA97387U UAU201411061U UAU201411061U UA97387U UA 97387 U UA97387 U UA 97387U UA U201411061 U UAU201411061 U UA U201411061U UA U201411061 U UAU201411061 U UA U201411061U UA 97387 U UA97387 U UA 97387U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- prevention
- treatment
- nephro
- causal
- Prior art date
Links
Abstract
Спосіб диференційованої нефрогепатопротекторної терапії та профілактики захворювань нирок, що виникають при проведенні етіотропного протитуберкульозного лікування у хворих на вперше діагностований туберкульоз легень полягає в тому, що в залежності від рівня біохімічних показників крові - мікроальбумінурії, аланін амінотрансферази, аспартатамінотрансферази застосовують нефропротекторні препарати.The method of differentiated nephrohepatoprotective therapy and prevention of kidney diseases arising from the conduct of etiotropic antituberculosis treatment in patients with newly diagnosed pulmonary tuberculosis is that, depending on the level of biopheromic indicators of blood, microalbumin, and microalbumin
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201411061U UA97387U (en) | 2014-10-10 | 2014-10-10 | Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201411061U UA97387U (en) | 2014-10-10 | 2014-10-10 | Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
UA97387U true UA97387U (en) | 2015-03-10 |
Family
ID=52990550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201411061U UA97387U (en) | 2014-10-10 | 2014-10-10 | Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA97387U (en) |
-
2014
- 2014-10-10 UA UAU201411061U patent/UA97387U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201792642A1 (en) | DIAGNOSTIC METHODS FOR T-CELL THERAPY | |
EA201790398A1 (en) | METHODS OF TREATING LIVER DISEASES | |
MX2016009060A (en) | Methods and systems for determining risk of heart failure. | |
PH12016501809A1 (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
BR112017016952A2 (en) | combination therapy with coagulation factors and multispecific antibodies | |
EA201691314A1 (en) | THERAPEUTIC WAYS AND COMPOSITIONS | |
MX2018004170A (en) | Biomarkers related to interleukin-33 (il-33)-mediated diseases and uses thereof. | |
PH12016502167A1 (en) | Hdl theraphy markers | |
PH12018502593A1 (en) | Combinations of linagliptin and metformin | |
MX2019005401A (en) | Methods of treating alport syndrome using bardoxolone methyl or analogs thereof. | |
BR112017002637A2 (en) | methods to treat or prevent eye conditions | |
MX2018012493A (en) | Methods for monitoring and treating cancer. | |
EA201790444A1 (en) | HSP90-directed visualization and inflammation therapy and infection | |
NZ730664A (en) | A method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases | |
EA201790893A1 (en) | METHODS OF TREATMENT OF OPHTHALMOLOGICAL DISORDERS | |
MX2018002298A (en) | Methods of using interleukin-10 for treating diseases and disorders. | |
MX2017010516A (en) | Biomarkers for diagnosis and prognosis of corneal ectatic disorders. | |
MX2017006491A (en) | Compositions and methods for modulating at2r activity. | |
EA201691335A1 (en) | HEXAHYDROFUROPYRROLES AS INHIBITORS PDE1 | |
UA97387U (en) | Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis | |
WO2015157655A3 (en) | Method for predicting response to vegf targeted therapeutics | |
UA110302C2 (en) | Method of diagnosis of allergic rhinitis, combined with bronchial asthma in children | |
UA93315U (en) | Method for diagnosing failure of union in fracture | |
UA92857U (en) | Method of early detection of dismetabolic disorders and metabolic syndrome x that affect locomotive crews | |
EA201401218A2 (en) | METHOD OF NOSOLOGICAL EXPRESS DIAGNOSTICS |